SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mirror Image who wrote (1647)1/15/2016 12:57:30 AM
From: Mirror Image  Read Replies (1) of 2026
 
Sarissa filed a Schedule 13 D/a today.

Looks like I got their shares count to the DOT ( - the second time around =} ).

sec.gov

Agreement, form of Warrant and the Warrant Amendment, which are attached hereto as Exhibits 4, 5 and 5.1, respectively, and which are incorporated herein by reference.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Initial Schedule 13D is hereby amended and restated in its entirety to read as follows:

(a) After the First Closing, the Reporting Persons may be deemed to beneficially own, in the aggregate, 11,231,985 Shares (including 3,400,661 Shares underlying the Warrants) representing approximately 17.87% of the Issuer's outstanding Shares (based upon (i) the 50,414,481 Shares stated to be outstanding as of January 7, 2016 by the Issuer in the Subscription Agreement, (ii) the 7,831,324 Shares owned by the Sarissa Funds after giving effect to the First Closing under the Subscription Agreement, (iii) the 3,400,661 Shares underlying the Warrants held by the Sarissa Funds after giving effect to the First Closing

I am waiting for Aspire's 13 D. Curious as to how many shares they own.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext